Denaverine: Difference between revisions
Content deleted Content added
حسن علي البط (talk | contribs) m Removed Category:Esters; Adding category Category:Acetates (using HotCat) |
Anypodetos (talk | contribs) m Stub sorting |
||
| Line 42: | Line 42: | ||
[[Category:Acetates]] |
[[Category:Acetates]] |
||
{{pharma-stub}} |
|||
{{genito-urinary-drug-stub}} |
|||
[[de:Denaverin]] |
[[de:Denaverin]] |
||
Revision as of 18:38, 12 July 2010
 | |
| Clinical data | |
|---|---|
| Pregnancy category |
|
| Routes of administration | intramuscular injection, suppositories |
| ATCvet code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Bioavailability | 8% (suppositories), 37% (oral solution) |
| Metabolism | mainly hepatic, at least 11 metabolites |
| Elimination half-life | 34 hours |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C24H33NO3 |
| Molar mass | 383.52 g/mol g·mol−1 |
Denaverine is an antispasmodic drug. It was developed in Germany and patented in 1974. Denaverine hydrochloride is used in veterinary medicine under the trade name Sensiblex as a muscle relaxant for the myometrium of cows and dogs during childbirth.[1] Under the trade name Spasmalgan, it has also been used in humans for the treatment of urogenital and gastrointestinal spasms.[2]
Mechanism of action
Denaverine, like papaverine, acts as a phosphodiesterase inhibitor. Additionally, it has anticholinergic effects.[3]
References
- ^ Committee for Veterinary Medicinal Products: Denavering Hydrochloride Summary Report
- ^ Rote Liste (in German) (2005 ed.). Frankfurt. ISBN 3-87193-306-6.
- ^ Dinnendahl, V, Fricke, U, ed. (2010). Arzneistoff-Profile (in German). Vol. 4 (23 ed.). Eschborn, Germany: Govi Pharmazeutischer Verlag. ISBN 978-3-7741-98-46-3.
{{cite book}}: CS1 maint: multiple names: editors list (link)
 | This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |